Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
17.31x1.85x-0.23x1.9x4.97x7.91x - 69Cr
53.13x6.05x-0.77x4.94x20.09x27.92x2.81% 29TCr
23.05x1.94x-17.26x3.18x11.29x18.52x1.71% 6.85TCr
10.47x11.08x0.06x5.39x8.3x9.12x - 836.22Cr
15.44x1.33x0.75x1.92x6.61x7.97x2.89% 777.17Cr
22.09x6.03x1.5x6.5x17.77x18.56x-.--% 445.27Cr
42.7x2.54x-1.39x2.42x29.46x43.64x0.72% 377.44Cr
27.06x - 0.17x5.2x14.86x24.07x - 314.29Cr
104.05x - -0.64x - - - -.--% 261.7Cr
12.34x0.82x0.87x1.1x27.57x-75.12x4.15% 100Cr
46.31x7.26x-1.2x15.54x32.63x38.39x - 98Cr
-7.23x12.09x0.44x199.37x-6.42x-5.03x-.--% 94Cr
Average 30.56x 5.10x -1.47x 22.50x 15.20x 10.54x 1.53% 3.3TCr
Weighted average by Cap. 45.65x 5.30x -3.54x 5.06x 18.03x 25.16x 2.54%
Specialty & Advanced Pharmaceuticals
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!